CAPELLE PSYCHIATRE
ActiveSummary
CAPELLE PSYCHIATRE has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €84k and a net result of €82k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 32% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
73
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency65▲+39
Growth78▲+20
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity tight (current ratio 1.18 against 0.65 in 2024; short-term debt: 60.2% and cash: 10.2% of total assets), and 60.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
39.7%
Return on assets
39.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
15 d early
2024
140 d early
2023
23 d early
2022
13 d late
2021
7 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€84k▲ 4,076%
2024 · €2k
2021: €23k
2022: €95k
2023: €200k
2024: €2k
2021 → 2025
Total assets
€210k▼ 3.7%
2024 · €219k
2021: €41k
2022: €151k
2023: €273k
2024: €219k
2021 → 2025
Net result
€82k▼ 57.8%
2024 · €195k
2021: €21k
2022: €72k
2023: €148k
2024: €195k
2021 → 2025
Working capital
€23k
2024 · €-76k
2021: €8k
2022: €32k
2023: €121k
2024: €-76k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€23k-€95k▲ 312%€200k▲ 112%€2k▼ 99.0%€84k▲ 4,076%
Operating result€27k-€92k▲ 239%€193k▲ 110%€247k▲ 27.7%€120k▼ 51.5%
Net result€21k-€72k▲ 242%€148k▲ 106%€195k▲ 32.2%€82k▼ 57.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 52% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €210k
Fixed assets
€61k ▼ 21.2%
Current assets
€149k ▲ 5.9%
Equity and liabilities €210k
Equity
€84k ▲ 4,076%
Debt
€127k ▼ 41.4%
Debt's share of the balance-sheet total falls from 99.1% to 60.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€133k▼
2024 · €259k
Cash flow
€96k▼
2024 · €208k
Current ratio
1.18▲
2024 · 0.65
Debt to equity
1.52
ROE
98.6%
ROA
39.1%▼
2024 · 89.3%
Interest coverage
26.72▼
2024 · 454.84
Debt ≤ 1 year
€127k▼
2024 · €217k
Income taxes
€33k▼
2024 · €64k
Staff costs
€29k▼
2024 · €91k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet
Code20242025
Assets
Total assets20/58€219k€210k▼
Fixed assets21/28€78k€61k▼
Tangible fixed assets22/27€71k€61k▼
Plant, machinery and equipment23€58k€51k▼
Furniture and vehicles24€13k€10k▼
Financial fixed assets28€6k-
Current assets29/58€141k€149k▲
Amounts receivable within one year40/41€19k€117k▲
Trade receivables40€19k€2k▼
Other amounts receivable41-€115k
Cash at bank and in hand54/58€120k€21k▼
Deferred charges and accrued income490/1€2k€11k▲
Equity and liabilities
Total equity and liabilities10/49€219k€210k▼
Equity10/15€2k€84k▲
Contributions10/11€2k€2k=
Profit (loss) carried forward14-€82k
Amounts payable17/49€217k€127k▼
Amounts payable within one year42/48€217k€127k▼
Trade debts44€6k€19k▲
Suppliers440/4€6k€19k▲
Taxes, remuneration and social security45€169k€107k▼
Taxes450/3€157k€100k▼
Remuneration and social security454/9€12k€7k▼
Other amounts payable47/48€42k€583▼
Accrued charges and deferred income492/3-€206
Income statement
Code20242025
Remuneration, social security and pensions62€91k€29k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€13k▲
Other operating charges640/8€1k€400▼
Gross operating margin9900€352k€163k▼
Operating profit (loss)9901€247k€120k▼
Financial income75/76B€13k€270▼
Recurring financial income75€13k€270▼
Financial charges65/66B€570€5k▲
Recurring financial charges65€570€5k▲
Profit (loss) for the period before taxes9903€260k€115k▼
Income taxes67/77€64k€33k▼
Profit (loss) for the period9904€195k€82k▼
Profit (loss) for the period to be appropriated9905€195k€82k▼
Appropriation of the result
Profit (loss) to be appropriated9906€394k€82k▼
Profit (loss) brought forward from the previous period14P€198k-
Profit to be distributed694/7€394k€833▼
Return on contributions (dividend)694€394k€833▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
16-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
13-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2021net €195k ▲32.2%
Operating result €247k, net result €195k, both a record.
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €200kEq €200k ▲112%
3 profitable years in a row build equity to €200k.
13-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 13 days late
2022
24-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Maria Tillmansstraat 91070 AnderlechtGround area
229 m²
Building footprint
172 m²
Volume, LiDAR
1,530 m³
2 parcels, Brussels · tallest building 14.7 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
CAPELLE PSYCHIATRE
since 20202.310.514.660
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21001A0342/00K002 | Brussels | 129 m² | 1 · 71 m² | 12.0 m · 2 fl. |
| 21001A0368/00D004 | Brussels | 100 m² | 1 · 101 m² | 14.7 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ARN MED
BE 1000.529.363
Chaudfontaine · Eq €83,499
Dr. Marie-Sophia Feytons
BE 0534.858.394
Hasselt · Eq €83,559
Dr. Tatjana Van Der Heggen, Neonatologie
BE 0779.778.050
Antwerpen · Eq €83,476
Dr Olivier Theeuws
BE 0770.261.657
Voeren · Eq €83,649
DR. VAN RENTERGHEM VICTORIA, OFTALMOLOOG
BE 0799.673.245
Diest · Eq €83,687
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,004 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-12-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.